[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

November 2016 - July 1883

Decade

Year

Issue

March 27, 2013, Vol 309, No. 12, Pages 1201-1306

This Week in JAMA

This Week in JAMA

Abstract Full Text
free access
JAMA. 2013;309(12):1201-1201. doi:10.1001/jama.2012.145324
Viewpoint

A Systematic Plan for Firearms Law Reform

Abstract Full Text
JAMA. 2013;309(12):1231-1232. doi:10.1001/jama.2013.1127

Mental Illness and New Gun Law ReformsThe Promise and Peril of Crisis-Driven Policy

Abstract Full Text
JAMA. 2013;309(12):1233-1234. doi:10.1001/jama.2013.1113

The Economics of Genomic MedicineInsights From the IOM Roundtable on Translating Genomic-Based Research for Health

Abstract Full Text
JAMA. 2013;309(12):1235-1236. doi:10.1001/jama.2013.113

Crossing the Omic ChasmA Time for Omic Ancillary Systems

Abstract Full Text
JAMA. 2013;309(12):1237-1238. doi:10.1001/jama.2013.1579
A Piece of My Mind

The NRA Let Me Down

Abstract Full Text
JAMA. 2013;309(12):1239-1240. doi:10.1001/jama.2013.1302
Original Contribution

Effect of Disodium EDTA Chelation Regimen on Cardiovascular Events in Patients With Previous Myocardial InfarctionThe TACT Randomized Trial

Abstract Full Text
free access has multimedia
JAMA. 2013;309(12):1241-1250. doi:10.1001/jama.2013.2107

Lamas et al report results of the Trial to Assess Chelation Therapy (TACT), a randomized controlled trial analyzing whether EDTA-based chelation therapy reduced cardiovascular events in 1708 patients with a history of myocardial infarction. In editorials, Nissen and Bauchner et al discuss the evaluation of TACT.

Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis BronchiectasisThe BAT Randomized Controlled Trial

Abstract Full Text
free access
JAMA. 2013;309(12):1251-1259. doi:10.1001/jama.2013.1937

To determine the efficacy of macrolide maintenance treatment for adults with non–cystic fibrosis bronchiectasis, Altenburg and coauthors randomized 83 outpatients with 3 or more lower respiratory tract infections in the preceding year to receive azithromycin or placebo for 12 months. Elborn and Tunney provide comment in the related Editorial.

Effect of Long-term, Low-Dose Erythromycin on Pulmonary Exacerbations Among Patients With Non–Cystic Fibrosis BronchiectasisThe BLESS Randomized Controlled Trial

Abstract Full Text
free access
JAMA. 2013;309(12):1260-1267. doi:10.1001/jama.2013.2290

Serisier and coauthors evaluate the clinical efficacy and antimicrobial resistance cost of low-dose erythromycin for patients with non–cystic fibrosis bronchiectasis in a 12-month, double-blind, placebo-controlled trial. In an Editorial, Elborn and Tunney discuss long-term macrolide therapy for patients with bronchiectasis.

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection FractionA Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2013;309(12):1268-1277. doi:10.1001/jama.2013.2024

To determine the effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction, Redfield and coauthors conducted a trial of 216 patients randomized to sildenafil or placebo and measured peak oxygen consumption along with a variety of clinical status variables.

Editorial

Evaluation of the Trial to Assess Chelation Therapy (TACT)The Scientific Process, Peer Review, and Editorial Scrutiny

Abstract Full Text
free access
JAMA. 2013;309(12):1291-1292. doi:10.1001/jama.2013.2761

Concerns About Reliability in the Trial to Assess Chelation Therapy (TACT)

Abstract Full Text
free access
JAMA. 2013;309(12):1293-1294. doi:10.1001/jama.2013.2778

Macrolides and BronchiectasisClinical Benefit With a Resistance Price

Abstract Full Text
JAMA. 2013;309(12):1295-1296. doi:10.1001/jama.2013.2780

Is Sublingual Immunotherapy Ready for Use in the United States?

Abstract Full Text
JAMA. 2013;309(12):1297-1298. doi:10.1001/jama.2013.2739
JAMA Clinical Challenge

A 51-Year-Old Man With HIV and Cervicodorsal Lipodystrophy (Buffalo Hump)

Abstract Full Text
JAMA. 2013;309(12):1289-1290. doi:10.1001/jama.2013.2552
Medical News and Perspectives

After 50 Years, Newborn Screening Continues to Yield Public Health Gains

Abstract Full Text
JAMA. 2013;309(12):1215-1217. doi:10.1001/jama.2013.2087

Studies Probe Restoring Speech in Persons With Chronic Stroke-Related Aphasia

Abstract Full Text
JAMA. 2013;309(12):1217-1218. doi:10.1001/jama.2013.1253
Letters

Warfarin Treatment After Bioprosthetic Aortic Valve Replacement

Abstract Full Text
JAMA. 2013;309(12):1225-1226. doi:10.1001/jama.2013.1972

Warfarin Treatment After Bioprosthetic Aortic Valve Replacement—Reply

Abstract Full Text
JAMA. 2013;309(12):1225-1226. doi:10.1001/jama.2013.1978

Aspirin Use and Risk of Macular Degeneration

Abstract Full Text
JAMA. 2013;309(12):1226-1226. doi:10.1001/jama.2013.2038

Aspirin Use and Risk of Macular Degeneration

Abstract Full Text
JAMA. 2013;309(12):1227-1228. doi:10.1001/jama.2013.2035

Aspirin Use and Risk of Macular Degeneration—Reply

Abstract Full Text
JAMA. 2013;309(12):1227-1228. doi:10.1001/jama.2013.2041

Funding for Biomedical Research

Abstract Full Text
JAMA. 2013;309(12):1228-1229. doi:10.1001/jama.2013.1331

Funding for Biomedical Research—Reply

Abstract Full Text
JAMA. 2013;309(12):1228-1229. doi:10.1001/jama.2013.1346
Visualizing Health Policy

Medicaid Expansion Under the Affordable Care Act

Abstract Full Text
free access
JAMA. 2013;309(12):1219-1219. doi:10.1001/jama.2013.2481
Health Agencies Update

Fungal Infection in Florida

Abstract Full Text
JAMA. 2013;309(12):1220-1220. doi:10.1001/jama.2013.2584

Retinal Implant

Abstract Full Text
JAMA. 2013;309(12):1220-1220. doi:10.1001/jama.2013.2714

Teens and Substance Use

Abstract Full Text
JAMA. 2013;309(12):1220-1220. doi:10.1001/jama.2013.2716

Glucose During Pregnancy

Abstract Full Text
JAMA. 2013;309(12):1220-1220. doi:10.1001/jama.2013.2718
The Cover

Easter Sunday

Abstract Full Text
JAMA. 2013;309(12):1205-1205. doi:10.1001/jama.2012.176795
Poetry and Medicine

Virtual White Coat

Abstract Full Text
JAMA. 2013;309(12):1206-1206. doi:10.1001/jama.2012.71220
From the Centers for Disease Control and Prevention
JAMA Patient Page

Treatment of Varicose Veins

Abstract Full Text
free access
JAMA. 2013;309(12):1306-1306. doi:10.1001/jama.2013.1704
JAMA Masthead

About This Journal

Abstract Full Text
JAMA. 2013;309(12):1203-1203. doi:10.1001/jama.309.12.1203
Clinical Review

Sublingual Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and AsthmaA Systematic Review

Abstract Full Text
free access has expired quiz
JAMA. 2013;309(12):1278-1288. doi:10.1001/jama.2013.2049

Lin and coauthors report on the use of sublingual immunotherapy as a treatment for allergic rhinoconjunctivitis and asthma. In an accompanying Editorial, Nelson discusses whether sublingual immuotherapy is ready for use in the United States.

JAMA 100 Years Ago

THE RATTLESNAKE-VENOM TREATMENT OF EPILEPSY

Abstract Full Text
JAMA. 2013;309(12):1207-1207. doi:10.1001/jama.2012.145314
×